Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio-Techne (TECH) Other Non-Current Assets (2016 - 2025)

Historic Other Non-Current Assets for Bio-Techne (TECH) over the last 16 years, with Q4 2025 value amounting to $267.1 million.

  • Bio-Techne's Other Non-Current Assets fell 287.5% to $267.1 million in Q4 2025 from the same period last year, while for Dec 2025 it was $267.1 million, marking a year-over-year decrease of 287.5%. This contributed to the annual value of $283.9 million for FY2025, which is 743.61% up from last year.
  • Latest data reveals that Bio-Techne reported Other Non-Current Assets of $267.1 million as of Q4 2025, which was down 287.5% from $276.6 million recorded in Q3 2025.
  • In the past 5 years, Bio-Techne's Other Non-Current Assets ranged from a high of $285.3 million in Q2 2023 and a low of $11.6 million during Q2 2021
  • Its 5-year average for Other Non-Current Assets is $179.0 million, with a median of $268.0 million in 2025.
  • In the last 5 years, Bio-Techne's Other Non-Current Assets plummeted by 1439.88% in 2021 and then surged by 51630.85% in 2023.
  • Over the past 5 years, Bio-Techne's Other Non-Current Assets (Quarter) stood at $37.1 million in 2021, then skyrocketed by 43.36% to $53.2 million in 2022, then skyrocketed by 415.77% to $274.4 million in 2023, then rose by 0.23% to $275.0 million in 2024, then fell by 2.88% to $267.1 million in 2025.
  • Its Other Non-Current Assets was $267.1 million in Q4 2025, compared to $276.6 million in Q3 2025 and $283.9 million in Q2 2025.